Monika Hegi
Monika Hegi
Full Professor, Lausanne University Hospital, Switzerland
Verified email at chuv.ch
Title
Cited by
Cited by
Year
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
ME Hegi, AC Diserens, T Gorlia, MF Hamou, N De Tribolet, M Weller, ...
New England Journal of Medicine 352 (10), 997-1003, 2005
60452005
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the …
R Stupp, ME Hegi, WP Mason, MJ Van Den Bent, MJB Taphoorn, ...
The lancet oncology 10 (5), 459-466, 2009
54312009
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
A Malmström, BH Grønberg, C Marosi, R Stupp, D Frappaz, H Schultz, ...
The lancet oncology 13 (9), 916-926, 2012
903*2012
Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide
ME Hegi, AC Diserens, S Godard, PY Dietrich, L Regli, S Ostermann, ...
Clinical cancer research 10 (6), 1871-1874, 2004
8102004
Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
ME Hegi, L Liu, JG Herman, R Stupp, W Wick, M Weller, MP Mehta, ...
Journal of clinical oncology 26 (25), 4189-4199, 2008
7942008
European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Effects of …
R Stupp, ME Hegi, WP Mason, MJ van den Bent, MJ Taphoorn, ...
Lancet Oncol 10 (5), 459-466, 2009
7092009
Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial
R Stupp, S Taillibert, AA Kanner, S Kesari, DM Steinberg, SA Toms, ...
Jama 314 (23), 2535-2543, 2015
6682015
Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22
LA Cannon-Albright, DE Goldgar, LJ Meyer, CM Lewis, DE Anderson, ...
Science 258 (5085), 1148-1152, 1992
6531992
Stem cell-related" self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma
A Murat, E Migliavacca, T Gorlia, WL Lambiv, T Shay, MF Hamou, ...
Journal of clinical oncology 26 (18), 3015-24, 2008
6412008
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
M Weller, R Stupp, G Reifenberger, AA Brandes, MJ Van Den Bent, ...
Nature Reviews Neurology 6 (1), 39-51, 2010
6282010
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial
MR Gilbert, M Wang, KD Aldape, R Stupp, ME Hegi, KA Jaeckle, ...
Journal of clinical oncology 31 (32), 4085, 2013
6112013
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre …
R Stupp, ME Hegi, T Gorlia, SC Erridge, J Perry, YK Hong, KD Aldape, ...
The lancet oncology 15 (10), 1100-1108, 2014
5992014
In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice.
M Harvey, AT Sands, RS Weiss, ME Hegi, RW Wiseman, P Pantazis, ...
Oncogene 8 (9), 2457, 1993
5711993
Chemoradiotherapy in malignant glioma: standard of care and future directions
R Stupp, ME Hegi, MR Gilbert, A Chakravarti
Journal of Clinical Oncology 25 (26), 4127-4136, 2007
5282007
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE. 3
T Gorlia, MJ van den Bent, ME Hegi, RO Mirimanoff, M Weller, ...
The lancet oncology 9 (1), 29-38, 2008
4922008
Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial
R Stupp, S Taillibert, A Kanner, W Read, DM Steinberg, B Lhermitte, ...
Jama 318 (23), 2306-2316, 2017
4842017
Current concepts and management of glioblastoma
M Preusser, S De Ribaupierre, A Wöhrer, SC Erridge, M Hegi, M Weller, ...
Annals of neurology 70 (1), 9-21, 2011
4622011
Changing paradigms—an update on the multidisciplinary management of malignant glioma
R Stupp, ME Hegi, MJ Van Den Bent, WP Mason, M Weller, ...
The oncologist 11 (2), 165-180, 2006
4432006
Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed …
R Stupp, ME Hegi, B Neyns, R Goldbrunner, U Schlegel, PM Clement, ...
Journal of clinical oncology 28 (16), 2712-2718, 2010
4322010
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
M Weller, M Van Den Bent, JC Tonn, R Stupp, M Preusser, ...
The lancet oncology 18 (6), e315-e329, 2017
3852017
The system can't perform the operation now. Try again later.
Articles 1–20